Investigating how specific proteins in brain cells contribute to Alzheimer's disease.
Neuron and microglia-specific proteomic signatures of ERK mediated mechanisms of Alzheimer's disease.
This study is looking at how certain brain cells change as we age and in Alzheimer's disease, to find out how these changes might help us discover new ways to treat the condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10868445 on NIH RePORTER |
What this research studies
This research focuses on understanding the roles of neurons and microglia in Alzheimer's disease (AD) by examining the proteins involved in their functioning. The study utilizes a novel technique to analyze protein changes in these brain cells as they age and in the context of AD. By inhibiting a specific signaling pathway known as MAPK/ERK, researchers aim to uncover how these changes affect brain cell behavior and identify potential biomarkers for the disease. This approach could lead to new therapeutic strategies for AD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing cognitive decline or diagnosed with Alzheimer's disease.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and treatments for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in targeting similar pathways in neurodegenerative diseases, suggesting potential for success in this approach.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Rangaraju, Srikant — Yale University
- Study coordinator: Rangaraju, Srikant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.